Cipher Pharma Announces Amendment To Debt Agreement And Partial Prepayment Post author:Sam Post published:April 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Gene-RADAR Authorized For Zika Testing: Interview With Nanobiosym Founder And CEO, April 20, 2017 Disappointment Hits as Amgen's Repatha Prevents Heart Attacks, But Not Deaths March 16, 2017 It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017
It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017